English
Français
Español
Deutsch
Italiano
Português
Nederlands
Polski
Română
Svenska
Dansk
Suomi
Čeština
Ελληνικά
Magyar
SlovenčinaData temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 0/5 criteria met.
- ❌ Price trend failed
- ❌ Growth failed
- ❌ Debt failed
- ❌ P/E failed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2021 → 2022: -78.30%
Price change 2022 → 2023: -7.01%
Price change 2023 → 2024: 72.41%
Price change 2024 → 2025: -42.50%
Price change 2025 → 2026: -69.57%
Price change 2026 (year to date): -68.89%
Financial growth
Revenue CAGR (8 years): N/A
Earnings CAGR (8 years): N/A
Growth status: insufficient data or negative trend.
Debt
Debt-to-equity ratio: 0.86
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: -0.54
P/E > 25.0 (maximum threshold).
Correction (6 months)
Current correction: 71.31% from the high over 6 months.
Excessive correction (> 20.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="NYXH" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Nyxoah S.A. | – | 0.86 | – | 🔒 |
| Euroapi S.A. | – | 0.08 | −1.3 % | – |
| Guerbet S.A. | – | 1.64 | +5.5 % | – |
| Cellectis S.A. | – | 1.20 | +8.9 % | – |
| Adocia S.A. | – | 5.97 | +18.8 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Nyxoah S.A. over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2020 | 76,925 | -13.7 m | -17,746.4 % | n/a |
| 2021 | 949,861 | -30.8 m | -3,241.7 % | +1,134.8 % |
| 2022 | 3.4 m | -34.8 m | -1,012.5 % | +262.0 % |
| 2023 | 4.8 m | -48.2 m | -993.8 % | +41.0 % |
| 2024 | 5.0 m | -66.0 m | -1,310.2 % | +4.0 % |
| 2025 | 11.2 m | -100 m | -899.0 % | +121.6 % |
Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.
Accounts and financial health
Balance sheet and cash flow published by Nyxoah S.A. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 136 m | 94.9 m | 57.7 m | 85.6 m | 48.0 m |
| Total Debt | 11.7 m | 11.9 m | 12.7 m | 22.7 m | 42.1 m |
| Net Debt | -124 m | -6.0 m | -8.9 m | -11.5 m | 12.1 m |
| Equity | 149 m | 120 m | 98.0 m | 113 m | 49.1 m |
| Total assets | 171 m | 146 m | 124 m | 158 m | 118 m |
| Operating cash flow | -25.3 m | -28.8 m | -44.8 m | -49.2 m | -67.5 m |
| Investments (capex) | 1.5 m | 886,000 | 2.5 m | 1.2 m | 3.8 m |
| Free cash-flow | -37.2 m | -45.1 m | -55.7 m | -55.3 m | -68.3 m |
| Share buybacks | 0 | 0 | 0 | 0 | 0 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 |
Amounts in EUR, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.
Analyst consensus and forecasts
What the financial analysts covering Nyxoah S.A. publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Average target over the last 3 months: 3.10 USD (3 targets).
Track record against expectations: reported EPS above consensus 2 times over the last 12 releases.
Source: ratings and forecasts published by analysts, collected on 07/11/2026. An analyst rating or target is not a guarantee.
Dividends and earnings
Nyxoah S.A.: dividend history, last distributions, stock splits and earnings releases.
No known dividend for this company.
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 05/08/2026 | -0.67 | -0.47 | n/a |
| 12/05/2026 | -0.43 | -0.54 | n/a |
| 19/03/2026 | -0.68 | -0.65 | n/a |
| 13/11/2025 | -0.74 | -0.61 | n/a |
| 18/08/2025 | -0.63 | -0.62 | n/a |
| 14/05/2025 | -0.63 | -0.49 | n/a |
Factual data: ex-dividend history and earnings calendar, as of 05/11/2026. A past dividend does not guarantee the next one.
PEA and practical information
Frequently asked questions about Nyxoah S.A.
What is the Nyxoah S.A. share price?
Latest recorded price: 0.846 USD on 06/11/2026, for a market cap of 86.1 m USD.
What is the revenue of Nyxoah S.A.?
11.2 m USD for fiscal year 2025, with net income of -100 m USD (net margin -899.0 %).
What do analysts say about Nyxoah S.A.?
Out of 5 analysts: 4 buy or strong buy, 1 hold, 0 sell or strong sell. Average price target: 3.10 USD, i.e. +255.7 % from the share price.
How many employees does Nyxoah S.A. have?
183 full-time employees according to the latest published profile.
Who runs Nyxoah S.A.?
Olivier Taelman is the company's chief executive.